These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 19416206)

  • 1. Relaxin: an endogenous renoprotective factor?
    Hewitson TD; Samuel CS
    Ann N Y Acad Sci; 2009 Apr; 1160():289-93. PubMed ID: 19416206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relaxin regulates collagen overproduction associated with experimental progressive renal fibrosis.
    Samuel CS; Mookerjee I; Masterson R; Tregear GW; Hewitson TD
    Ann N Y Acad Sci; 2005 May; 1041():182-4. PubMed ID: 15956704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of progressive fibrosis in chronic renal diseases: antifibrotic agents.
    Negri AL
    J Nephrol; 2004; 17(4):496-503. PubMed ID: 15372410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relaxin and the progression of kidney disease.
    Samuel CS; Hewitson TD
    Curr Opin Nephrol Hypertens; 2009 Jan; 18(1):9-14. PubMed ID: 19077683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic targets for prevention and regression of progressive fibrosing renal diseases.
    Eitner F; Floege J
    Curr Opin Investig Drugs; 2005 Mar; 6(3):255-61. PubMed ID: 15816501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular and molecular events leading to renal tubulointerstitial fibrosis.
    Razzaque MS; Taguchi T
    Med Electron Microsc; 2002 Jun; 35(2):68-80. PubMed ID: 12181648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relaxin in cardiovascular and renal disease.
    Samuel CS; Hewitson TD
    Kidney Int; 2006 May; 69(9):1498-502. PubMed ID: 16672919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigations into the inhibitory effects of relaxin on renal myofibroblast differentiation.
    Samuel CS; Mookerjee I; Halls ML; Summers RJ; Chew E; Bathgate RA; Tregear GW; Hewitson TD
    Ann N Y Acad Sci; 2009 Apr; 1160():294-9. PubMed ID: 19416207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGF-beta in renal injury and disease.
    Böttinger EP
    Semin Nephrol; 2007 May; 27(3):309-20. PubMed ID: 17533008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relaxin decreases renal interstitial fibrosis and slows progression of renal disease.
    Garber SL; Mirochnik Y; Brecklin CS; Unemori EN; Singh AK; Slobodskoy L; Grove BH; Arruda JA; Dunea G
    Kidney Int; 2001 Mar; 59(3):876-82. PubMed ID: 11231342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of cardiac fibrosis and related dysfunction by relaxin.
    Du XJ; Xu Q; Lekgabe E; Gao XM; Kiriazis H; Moore XL; Dart AM; Tregear GW; Bathgate RA; Samuel CS
    Ann N Y Acad Sci; 2009 Apr; 1160():278-84. PubMed ID: 19416203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct contribution of epithelium to organ fibrosis: epithelial-mesenchymal transition.
    Guarino M; Tosoni A; Nebuloni M
    Hum Pathol; 2009 Oct; 40(10):1365-76. PubMed ID: 19695676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relaxin and the extracellular matrix: molecular mechanisms of action and implications for cardiovascular disease.
    McGuane JT; Parry LJ
    Expert Rev Mol Med; 2005 Sep; 7(21):1-18. PubMed ID: 16191259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of relaxin in regulation of fibrosis in the lung.
    Tang ML; Samuel CS; Royce SG
    Ann N Y Acad Sci; 2009 Apr; 1160():342-7. PubMed ID: 19416216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relaxin: antifibrotic properties and effects in models of disease.
    Samuel CS
    Clin Med Res; 2005 Nov; 3(4):241-9. PubMed ID: 16303890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ECM homeostasis in renal diseases: a genomic approach.
    Eikmans M; Baelde JJ; de Heer E; Bruijn JA
    J Pathol; 2003 Jul; 200(4):526-36. PubMed ID: 12845620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal tubulointerstitial fibrosis: common but never simple.
    Hewitson TD
    Am J Physiol Renal Physiol; 2009 Jun; 296(6):F1239-44. PubMed ID: 19144691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of relaxin's antifibrotic action by SELDI-TOF mass spectrometry-based profiling of relaxin knockout mice, a model of progressive fibrosis.
    Giannakis E; Macris M; Chan L; Tregear GW; Samuel CS; Wade JD
    Ann N Y Acad Sci; 2009 Apr; 1160():350-2. PubMed ID: 19416218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current view on mediators role in pathogenesis of renal interstitial fibrosis (review)].
    Ratner MIa
    Ter Arkh; 1997; 69(12):87-8. PubMed ID: 9503546
    [No Abstract]   [Full Text] [Related]  

  • 20. Relaxin: exploring the antifibrotic potential of a pregnancy hormone.
    Gaedeke J; Peters H
    Kidney Int; 2005 Jul; 68(1):405-6. PubMed ID: 15954933
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.